• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶特异性淋巴结清扫术对cN0-1期非小细胞肺癌是否足够?

Is lobe specific lymph node dissection adequate for cN0-1 non-small cell lung cancer?

作者信息

Fang Likui, Xu Jinming, Ye Bo, Yu Guocan, Chen Gang, Yang Jun

机构信息

Department of Thoracic Surgery, Hangzhou Red Cross Hospital, Hangzhou, 310003, China.

Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

出版信息

J Cardiothorac Surg. 2020 Feb 27;15(1):46. doi: 10.1186/s13019-020-1087-4.

DOI:10.1186/s13019-020-1087-4
PMID:32106870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7045366/
Abstract

PURPOSE

This study aims to explore whether lobe specific lymph node dissection (LND) is adequate for cN0-1 non-small cell lung cancer (NSCLC) or not.

METHODS

Among 5613 cN0-1 NSCLC patients, 394 cases (7.0%) with pN2 were enrolled and the distribution of mediastinal lymph node metastasis was analyzed. The included patients were divided into the non-lobe specific lymph node metastasis (NLSLNM) group and the lobe specific lymph node metastasis (LSLNM) group. The clinicopathological characteristics were compared between two groups and multivariable analysis was performed to find independent factors predicting NLSLNM.

RESULTS

The incidence of pN2 cases deserved serious attention. The proportion of upper zone lymph node metastases was not rare in right (55.0%) and left (35.7%) lower lobe tumors. The proportion of subcarinal zone lymph node involvement was also high in right (21.8%) and left (25.8%) upper lobe tumors. Multivariable analysis showed that elevated carcinoembryonic antigen (CEA) level (P = 0.034), right lower lobe (RLL) tumors (P = 0.022) and station 11 involvement (P = 0.030) were independent risk factors for NLSLNM.

CONCLUSION

Systematic LND seems to be superior to lobe specific LND in the assessment of lymph node status and high CEA level, RLL tumors and station 11 involvement are predictors for NLSLNM.

摘要

目的

本研究旨在探讨肺叶特异性淋巴结清扫术(LND)对于cN0-1期非小细胞肺癌(NSCLC)是否足够。

方法

在5613例cN0-1期NSCLC患者中,纳入394例(7.0%)pN2患者,分析纵隔淋巴结转移的分布情况。将纳入的患者分为非肺叶特异性淋巴结转移(NLSLNM)组和肺叶特异性淋巴结转移(LSLNM)组。比较两组的临床病理特征,并进行多变量分析以找出预测NLSLNM的独立因素。

结果

pN2病例的发生率值得严重关注。在右下叶肿瘤中,上区淋巴结转移的比例在右侧(55.0%)和左侧(35.7%)并不少见。在右上叶肿瘤中,隆突下区淋巴结受累的比例在右侧(21.8%)和左侧(25.8%)也很高。多变量分析显示,癌胚抗原(CEA)水平升高(P = 0.034)、右下叶(RLL)肿瘤(P = 0.022)和第11组淋巴结受累(P = 0.030)是NLSLNM的独立危险因素。

结论

在评估淋巴结状态方面,系统性LND似乎优于肺叶特异性LND,而CEA水平升高、RLL肿瘤和第11组淋巴结受累是NLSLNM的预测因素。

相似文献

1
Is lobe specific lymph node dissection adequate for cN0-1 non-small cell lung cancer?叶特异性淋巴结清扫术对cN0-1期非小细胞肺癌是否足够?
J Cardiothorac Surg. 2020 Feb 27;15(1):46. doi: 10.1186/s13019-020-1087-4.
2
Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.Ⅰ期非小细胞肺癌患者纵隔淋巴结受累:合理淋巴结清扫术的可能性。
J Thorac Oncol. 2015 Jun;10(6):930-6. doi: 10.1097/JTO.0000000000000546.
3
Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients.临床ⅠA 期纯磨玻璃密度非小细胞肺癌患者纵隔淋巴结清扫术的研究。
J Cardiothorac Surg. 2024 Jun 24;19(1):357. doi: 10.1186/s13019-024-02839-z.
4
[Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].[临床I a期非小细胞肺癌淋巴结清扫的适宜范围]
Ai Zheng. 2007 Mar;26(3):303-6.
5
Metastatic pathways to the lower zone by segment in patients with clinical T1 lower lobe non-small cell lung cancer.临床 T1 下叶非小细胞肺癌患者下段转移途径的节段分布。
Gen Thorac Cardiovasc Surg. 2024 Oct;72(10):684-689. doi: 10.1007/s11748-024-02021-1. Epub 2024 Mar 18.
6
Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.前哨淋巴结取样限制了I期非小细胞肺癌的淋巴结清扫术。
Eur J Cardiothorac Surg. 2007 Aug;32(2):356-61. doi: 10.1016/j.ejcts.2007.04.030. Epub 2007 May 21.
7
Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.临床 I 期肺癌患者切除及纵隔淋巴结清扫术后隐匿性 pN2 疾病的发生率。
Eur J Cardiothorac Surg. 2017 Apr 1;51(4):674-679. doi: 10.1093/ejcts/ezw400.
8
Lymph node metastasis outside of a tumor-bearing lobe in primary lung cancer and the status of interlobar fissures: The necessity for removing lymph nodes from an adjacent lobe.原发性肺癌中肿瘤所在肺叶以外的淋巴结转移及叶间裂状态:从相邻肺叶切除淋巴结的必要性。
Medicine (Baltimore). 2019 Mar;98(12):e14800. doi: 10.1097/MD.0000000000014800.
9
[Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].[根据肺癌发生部位及组织学类型进行合理的淋巴结清扫术]
Kyobu Geka. 2001 Dec;54(13):1073-8; discussion 1078-81.
10
Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.在所有非小细胞肺癌肺叶切除术中均应清扫隆突下淋巴结——无论原发肿瘤位置如何。
Ann Thorac Surg. 2017 Apr;103(4):1121-1125. doi: 10.1016/j.athoracsur.2016.09.109. Epub 2017 Jan 18.

引用本文的文献

1
Lymph node dissection of station 8 improves the survival of TN0M0 lung adenocarcinoma patients.第8组淋巴结清扫可提高TN0M0期肺腺癌患者的生存率。
Transl Lung Cancer Res. 2024 Jul 30;13(7):1530-1543. doi: 10.21037/tlcr-24-184. Epub 2024 Jul 12.
2
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.加拿大可切除 II/III 期非小细胞肺癌管理共识推荐意见:一项改良 Delphi 流程的研究结果。
Curr Oncol. 2023 Dec 6;30(12):10363-10384. doi: 10.3390/curroncol30120755.
3
[Risk Factors and Sampling Range Evaluation of Lymph node Metastasis for 
Non-small Cell Lung Cancer with Diameter ≤2 cm].直径≤2cm的非小细胞肺癌淋巴结转移的危险因素及采样范围评估
Zhongguo Fei Ai Za Zhi. 2023 Jul 20;26(7):507-514. doi: 10.3779/j.issn.1009-3419.2023.102.26.
4
Non-Lobe Specific Metastases in Occult N2 after Lobectomy for Clinical N0 Non-Small Cell Lung Cancer.临床N0期非小细胞肺癌肺叶切除术后隐匿性N2期非肺叶特异性转移
Int J Cancer Med. 2023;6(2):58-68. Epub 2022 Nov 30.
5
Effect of 3A lymph node resection on survival in patients with right-sided NSCLC: a retrospective, multicentre, propensity-score matching study.3A 组淋巴结切除术对右侧非小细胞肺癌患者生存的影响:一项回顾性、多中心、倾向评分匹配研究
J Thorac Dis. 2022 Sep;14(9):3265-3276. doi: 10.21037/jtd-21-1957.
6
Imbalanced Data Correction Based PET/CT Radiomics Model for Predicting Lymph Node Metastasis in Clinical Stage T1 Lung Adenocarcinoma.基于不平衡数据校正的PET/CT影像组学模型预测临床T1期肺腺癌淋巴结转移
Front Oncol. 2022 Jan 28;12:788968. doi: 10.3389/fonc.2022.788968. eCollection 2022.
7
Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer.肺腺癌患者癌胚抗原升高行肺叶特异性淋巴结清扫术的可接受结局
Medicina (Kaunas). 2021 Dec 14;57(12):1365. doi: 10.3390/medicina57121365.
8
Video-assisted versus open thoracotomy lobectomy: comparison on lymphadenectomy and survival in early stage of lung cancer.电视辅助与开胸肺叶切除术:早期肺癌淋巴结清扫及生存情况比较
J Thorac Dis. 2021 Jan;13(1):101-112. doi: 10.21037/jtd-20-2251.
9
How we assess the perioperative anxiety of surgical patients with pulmonary nodules: the revision of state-trait anxiety inventory.我们如何评估肺部结节手术患者的围手术期焦虑:状态-特质焦虑量表的修订。
J Cardiothorac Surg. 2020 Oct 28;15(1):324. doi: 10.1186/s13019-020-01338-1.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.非小细胞肺癌中叶特异性纵隔淋巴结转移的发生率和分布:来自 4511 例切除病例的数据。
Ann Surg Oncol. 2018 Oct;25(11):3300-3307. doi: 10.1245/s10434-018-6394-9. Epub 2018 Aug 6.
3
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).一项针对临床 I-II 期非小细胞肺癌的肺叶特异性与系统性淋巴结清扫的随机 III 期试验(JCOG1413)。
Jpn J Clin Oncol. 2018 Feb 1;48(2):190-194. doi: 10.1093/jjco/hyx170.
5
Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.临床 I 期肺癌患者切除及纵隔淋巴结清扫术后隐匿性 pN2 疾病的发生率。
Eur J Cardiothorac Surg. 2017 Apr 1;51(4):674-679. doi: 10.1093/ejcts/ezw400.
6
Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.肺癌——美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Mar;67(2):138-155. doi: 10.3322/caac.21390. Epub 2017 Jan 31.
7
Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.肺叶特异性淋巴结清扫术作为非小细胞肺癌手术的标准程序:一项倾向评分匹配研究。
J Thorac Oncol. 2017 Jan;12(1):85-93. doi: 10.1016/j.jtho.2016.08.127. Epub 2016 Aug 20.
8
Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.肺叶特异性淋巴结清扫术治疗Ⅰ期和Ⅱ期非小细胞肺癌:日本多机构回顾性研究采用倾向评分分析。
J Thorac Oncol. 2016 Sep;11(9):1529-37. doi: 10.1016/j.jtho.2016.05.014. Epub 2016 May 29.
9
Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.发现未被怀疑的pN2疾病时非小细胞肺癌肺叶切除术后的长期结局:一项国家癌症数据库分析
J Thorac Cardiovasc Surg. 2016 May;151(5):1380-8. doi: 10.1016/j.jtcvs.2015.12.028. Epub 2015 Dec 21.
10
Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.临床I期非小细胞肺癌解剖性肺段切除术与肺叶切除术的复发及生存结果:一项倾向评分匹配分析
J Clin Oncol. 2014 Aug 10;32(23):2449-55. doi: 10.1200/JCO.2013.50.8762. Epub 2014 Jun 30.